(University of Michigan Health System) University of Michigan scientists have identified key steps in breast-tissue cell division that go awry when CHFR's action is low or absent.
The gene's expression is missing in more than a third of breast cancers. The findings could make it possible to identify which patients are more likely to benefit from taxanes, a class of widely used cancer drugs which includes paclitaxel and docetaxel.
Sponsors
Post new comment